Table 1.
Cancer groups | Patient No. | Gender | Age | TNM* | Staging |
---|---|---|---|---|---|
LCNEC | 1 | F | 68 | T1N0M0 | IA |
2 | M | 73 | T2N0M0 | IB | |
3 | M | 58 | T1N1M0 | IIA | |
4 | M | 70 | T2N0M0 | IB | |
5 | M | 76 | T2N2M0 | IIIA | |
6 | M | 69 | T3N3M0 | IIIB | |
7 | M | 64 | T2N1M0 | IIB | |
8 | M | 60 | T2N2M0 | IIIA | |
9 | F | 77 | T1N0M0 | IA | |
10 | M | 69 | T1N2M0 | IIIA | |
SCLC | 1 | F | 62 | T2N0M0 | IB |
2 | M | 77 | T2N1M0 | IIB | |
3 | M | 57 | T2N1M0 | IIB | |
4 | M | 76 | T1N1M0 | IIA | |
5 | M | 64 | T1N1M0 | IIA | |
6 | F | 70 | T1N1M0 | IIA | |
7 | M | 69 | T1N1M0 | IIA | |
8 | M | 77 | T2N0M0 | IB | |
9 | M | 73 | T1N0M0 | IA | |
10 | M | 73 | T2N1M0 | IIB | |
LCC | 1 | M | 52 | T2N1M0 | IIB |
2 | M | 71 | T1N0M0 | IA | |
3 | F | 57 | T1N0M0 | IA | |
4 | M | 51 | T4N2M0 | IIIB | |
5 | M | 72 | T1N1M0 | IIA | |
6 | M | 67 | T1N1M0 | IIA | |
7 | M | 67 | T2N0M0 | IB | |
8 | M | 58 | T1N0M0 | IA | |
9 | M | 67 | T2N0M0 | IB | |
10 | M | 66 | T1N0M0 | IA |
*Ref. [31]